Welcome to our dedicated page for High Tide SEC filings (Ticker: HITI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The High Tide Inc. (HITI) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer with securities listed in the United States. High Tide files its annual disclosure on Form 40-F and furnishes current information on Form 6-K under the Securities Exchange Act of 1934.
Recent Form 6-K filings for High Tide have attached company news releases as exhibits. These filings cover topics such as new Canna Cabana store openings in Canadian provinces, the launch of an international Canna Cabana location in Berlin, participation in investor conferences, and recognition in external business rankings. Some 6-Ks also reference material change reports and other corporate updates that the company furnishes to U.S. investors.
For those analyzing HITI, these SEC filings help document how High Tide communicates its strategy, expansion plans, and operational milestones to the market. They complement the company’s Canadian disclosure on SEDAR+ and provide a U.S. regulatory record of its news releases and material changes. Because High Tide operates across cannabis retail, e-commerce, and German medical cannabis distribution, its filings can touch on developments in each of these areas.
On Stock Titan, users can view High Tide’s latest 6-K submissions as they are made available through EDGAR. The platform associates each filing with AI-powered tools that can assist in understanding the contents and context of the documents, helping readers navigate the company’s ongoing regulatory communications more efficiently.
High Tide Inc. reported strong first fiscal quarter 2026 results, with revenue of $178,329 thousand, up 25% from $142,461 thousand a year earlier. Gross profit also rose 25% to $44,409 thousand, keeping gross margin steady at 25%, showing the business is growing while maintaining pricing and cost discipline.
Adjusted EBITDA improved to $11,457 thousand, a 62% increase from $7,089 thousand, and Adjusted EBITDA margin edged up to 6%. Net loss narrowed significantly to $352 thousand from $2,689 thousand, and basic and diluted income (loss) per share improved to $0.01 from $(0.03).
Cash generation improved meaningfully. Net cash provided by operating activities was $5,860 thousand versus $683 thousand, and free cash flow swung to a positive $2,939 thousand from negative $1,900 thousand. Management highlighted record revenue exceeding $700 million annualized, continued expansion of Canna Cabana’s 220-store Canadian network, growing German medical cannabis sales through Remexian, and recovering U.S. e-commerce trends.
High Tide Inc. reported much stronger results for the quarter ended January 31, 2026. Revenue rose 25% to $178.3M, driven mainly by Canadian bricks-and-mortar sales of $149.7M and medical cannabis distribution revenue of $25.0M from Remexian in Germany.
Gross profit increased 25% to $44.4M, maintaining a 25% gross margin. Income from operations improved to $2.4M from $0.1M, while the net loss narrowed to $0.4M. Adjusted EBITDA grew 62% to $11.5M, and free cash flow swung to a positive $2.9M from a $1.9M outflow.
The company ended the quarter with total assets of $346.4M, shareholders’ equity of $102.0M, and cash and restricted cash of $46.4M. High Tide operated 218 Canadian retail stores as of January 31, 2026 and highlighted rapid growth in its Cabana Club and Elite loyalty programs.
High Tide Inc. filed a report highlighting the opening of its 220th Canna Cabana cannabis store, located on London Road in Sarnia, Ontario, which will start selling adult-use products on March 9, 2026. This is the Company’s first store in Sarnia and its 96th location in Ontario.
High Tide also announced it will release financial and operational results for the quarter ended January 31, 2026 after markets close on March 17, 2026, followed by a webcast on March 18, 2026 with its CEO and CFO to discuss the results and outlook.
High Tide Inc. filed a Form 6-K highlighting that it and its U.S. hemp-derived CBD subsidiary NuLeaf Naturals have joined the U.S. National Compassionate Care Council as founding members. The Council focuses on improving patient access to cannabinoid therapies through modernized, evidence-based healthcare standards.
Management notes that recent U.S. federal initiatives to reschedule cannabis and explore Medicare reimbursement for hemp-derived cannabinoid products could materially affect High Tide’s American CBD operations. The filing also profiles High Tide’s broader business, including its 219-location Canna Cabana retail chain with a 12% Canadian market share and its German medical cannabis distributor Remexian Pharma.
High Tide Inc. reported board and leadership changes alongside new equity awards. Two long-serving directors, Nitin Kaushal and Andrea Elliott, resigned effective March 2, 2026, and were replaced by Kathleen Skerrett, a securities and governance lawyer, and technology entrepreneur Menashe Kestenbaum.
The company also added David Wallach and Filip Ernest to its Advisory Board to guide real estate, business development, artificial intelligence, e-commerce and stakeholder initiatives. To align incentives, High Tide granted 123,558 restricted stock units and 25,000 stock options, each option exercisable at $3.43 per share for three years, under its omnibus equity plan and subject to statutory holding periods.
High Tide Inc. filed a 6-K highlighting operational expansion and new equity incentives. The company opened a new Canna Cabana retail cannabis store at 3148 Kingston Road in Scarborough, Ontario, bringing its network to 219 Canna Cabana locations across Canada and 95 in Ontario. Management describes the site as a high-traffic corridor with limited nearby cannabis competition and a history of strong retail performance.
High Tide also granted 145,500 stock options exercisable at $3.22 per share until February 6, 2029, vesting over two years, and 1,300,530 restricted stock units to directors, officers, employees, and consultants. Of the RSUs, 48% vest on February 6, 2027, 26% on February 6, 2028, and the remaining 26% on February 6, 2029. Directors received an aggregate of 795,106 RSUs, treated as a related-party transaction under MI 61-101, but exempt from formal valuation and minority approval because the fair market value and consideration are each below 25% of the company’s market capitalization.
High Tide Inc., a Canadian cannabis retailer and accessories company listed on the TSX Venture Exchange and Nasdaq, filed Amendment No. 1 to its Annual Report on Form 40-F for the year ended October 31, 2025. The amendment mainly corrects typographical errors in several narrative sections and refiles two auditor consent exhibits that were missing signatures; all other disclosures from the original report remain unchanged.
High Tide reports 87,235,986 common shares outstanding as of October 31, 2025 and discloses total contractual obligations of about $214.5 million, primarily lease commitments, accounts payable, debentures, and a junior secured convertible loan. The company highlights extensive forward-looking information about planned growth, acquisitions, and financing facilities, along with detailed risk factors, including regulatory uncertainty around U.S. hemp-derived Delta-8 and Delta-9 products and potential impacts on U.S. listings. As a foreign private issuer and emerging growth company, High Tide uses IFRS, follows Canadian governance practices with some Nasdaq exceptions, has an independent audit committee with an identified financial expert, and currently has no off-balance sheet arrangements.
High Tide Inc. reported record results for fiscal 2025 while remaining free cash flow positive. Revenue reached $164 million in Q4 2025, with full-year revenue of $593.986 million, up 14% year over year. Q4 adjusted EBITDA rose to $12.414 million, a 51% increase, and full-year adjusted EBITDA was $38.208 million, roughly flat versus 2024.
The company generated $12.002 million in free cash flow for fiscal 2025 despite higher expenses and a larger net loss, driven partly by non-cash items such as impairments and fair value changes. High Tide expanded its Canna Cabana footprint to 218 stores, opened 27 new locations in calendar 2025, and grew Cabana Club membership to 2.50 million in Canada and 6.56 million globally.
Internationally, High Tide closed a majority acquisition of Remexian Pharma in Germany and reached 2.6 tonnes of monthly distribution in December 2025. Management expects to remain free cash flow positive in fiscal 2026, add 20–30 Canadian stores in calendar 2026, and expand higher-margin white label brands and Remexian’s international reach.
High Tide Inc., a Canadian cannabis retailer and foreign private issuer, has filed its annual report on Form 40-F under the MJDS, using IFRS rather than U.S. GAAP. Its common shares trade on the TSX Venture Exchange and Nasdaq under the symbol HITI.
The report highlights extensive forward-looking statements and future-oriented financial information tied to growth plans, acquisitions, store development, and use of credit facilities, alongside significant regulatory and legal risks around cannabis, hemp, and Delta-8/Delta-9 products in the United States and Canada.
As of October 31, 2025, High Tide had 87,235,986 common shares outstanding and total contractual obligations of C$214,478 thousand, including lease obligations, notes, secured debentures, and a junior secured convertible loan. The company reports no off-balance sheet arrangements, qualifies as an emerging growth company exempt from auditor ICFR attestation, and follows certain Canadian practices for Nasdaq corporate governance.